Homology Medicines Inc.
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$0.04avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Homology Medicines Inc. in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Erste Asset Management GmbH ($22K).
- Company
- Homology Medicines Inc.
- CUSIP
- 438CVR029
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Erste Asset Management GmbH | 0.00% | No change | 540,000 | $22K |
"% of holder's portfolio" is HOMOLOGY MEDICINES INC's weight in each manager's 13F, not the share of Homology Medicines Inc. the manager owns.